Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(29 sites)

United States

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Tower Cancer Research Foundation, Beverly Hills, California

Loma Linda University Medical Center, Loma Linda, California

Cedars Sinai Medical Center, Los Angeles, California

UCSF Medical Center-Mission Bay, San Francisco, California

Torrance Memorial Physician Network - Cancer Care, Torrance, California

MedStar Georgetown University Hospital, Washington D.C., District of Columbia

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida

UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida

UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois

University of Chicago Medicine-Orland Park, Orland Park, Illinois

UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa

Iowa Methodist Medical Center, Des Moines, Iowa

UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa

Dana-Farber Cancer Institute, Boston, Massachusetts

Mayo Clinic in Rochester, Rochester, Minnesota

Missouri Baptist Medical Center, St Louis, Missouri

Duke University Medical Center, Durham, North Carolina

Case Western Reserve University, Cleveland, Ohio

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Temple University Hospital, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah